The TÜSİAD New York Network, as part of its AI Connect Series, organized a webinar on the role of artificial intelligence in healthcare.
The session featured Tendü Yoğurtçu, PhD, TÜSİAD New York Network AI Group Leader and Ümit Topaloğlu, PhD, FAMIA, Chief of Clinical and Translational Research Informatics at the National Cancer Institute, National Institutes of Health.
The discussion focused on one of the most important questions facing the healthcare sector today: how can AI move from promising research and pilot projects to scalable, measurable impact? Speakers explored how AI is already reshaping healthcare, from clinical trial design and diagnostics to precision medicine and research decision-making.
Dr. Topaloğlu and Dr. Yoğurtçu examined where AI is creating tangible value today, how it is supporting clinicians and researchers, and what challenges continue to limit broader adoption. The conversation also highlighted the importance of data quality, institutional readiness, responsible implementation, privacy and security considerations, and cross-sector collaboration in translating AI innovation into real-world healthcare outcomes.
The session underscored that while AI holds significant promise for transforming healthcare, its long-term impact will depend on the ability of institutions to bridge the gap between experimentation and practical deployment.
The event concluded with an engaging Q&A session, featuring thoughtful questions from professionals in the field who are closely following the latest developments in AI and healthcare.